Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum

Journal of Pathology

Volumn 229, Issue 4, 2013, Pages 579-587

  Matsubara, Akiko ^a   Sekine, Shigeki ^a   Kushima, Ryoji ^a   Ogawa, Reiko ^a   Taniguchi, Hirokazu ^a   Tsuda, Hitoshi ^a   Kanai, Yae ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

GNAS; KRAS; pyloric gland adenoma; stomach, duodenum

Indexed keywords

MISMATCH REPAIR PROTEIN;

ADENOMA; ADULT; AGED; ARTICLE; BRAF GENE; CLINICAL ARTICLE; CTNNB1 GENE; DUODENUM ADENOMATOSIS; FEMALE; FOVEOLAR TYPE ADENOMA; GENE; GENE MUTATION; GNAS GENE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINAL TYPE ADENOMA; KRAS GENE; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; PYLORIC GLAND ADENOMA; STOMACH ADENOCARCINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADENOMA; ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; DNA MUTATIONAL ANALYSIS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; DUODENAL NEOPLASMS; DUODENUM; FEMALE; GASTRIC MUCOSA; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; STOMACH NEOPLASMS;

EID: 84874109101     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4153     Document Type: Article

References (37)

1. Laxen F, Sipponen P, Ihamaki T, et al,. Gastric polyps; their morphological and endoscopical characteristics and relation to gastric carcinoma. Acta Pathol Microbiol Immunol Scand A 1982; 90: 221-228.
2. Abraham SC, Montgomery EA, Singh VK, et al,. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol 2002; 26: 1276-1285.
3. Lauwers GY, Carnerio F, Graham DY, et al,. Gastric carcinoma. In WHO Classification of Tumours of the Digestive System, 4th edn, Bosman F, Carmeiro F, Hruban RH, et al. (eds). International Agency for Research on Cancer: Lyon, 2010: 48-68.
4. Shepherd N, Carr NJ, Howe JR, et al,. Carcinoma of the small intestine. In WHO Classification of Tumours of the Digestive System, 4th edn, Bosman F, Carmeiro F, Hruban RH, et al. (eds). International Agency for Research on Cancer: Lyon, 2010: 98-101.
5. Kushima R, Ruthlein HJ, Stolte M, et al,. 'Pyloric gland-type adenoma' arising in heterotopic gastric mucosa of the duodenum, with dysplastic progression of the gastric type. Virchows Arch 1999; 435: 452-457.
6. Vieth M, Kushima R, Borchard F, et al,. Pyloric gland adenoma: a clinico-pathological analysis of 90 cases. Virchows Arch 2003; 442: 317-321.
7. Chen ZM, Scudiere JR, Abraham SC, et al,. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma. Am J Surg Pathol 2009; 33: 186-193.
8. Odze R, Goldblum J, Crawford J, (eds). Polyps of the Stomach, 2nd edn. Saunders: Philadelphia, PA, 2009.
9. Kushima R, Vieth M, Borchard F, et al,. Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer 2006; 9: 177-184.
10. Vieth M, Kushima R, Mukaisho K, et al,. Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53. Virchows Arch 2010; 457: 529-536.
11. Landis CA, Masters SB, Spada A, et al,. GTPase inhibiting mutations activate the α-chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 1989; 340: 692-696.
12. Freda PU, Chung WK, Matsuoka N, et al,. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission. Pituitary 2007; 10: 275-282.
13. Weinstein LS, Liu J, Sakamoto A, et al,. Minireview. GNAS: normal and abnormal functions. Endocrinology 2004; 145: 5459-5464.
14. Lyons J, Landis CA, Harsh G, et al,. Two G protein oncogenes in human endocrine tumors. Science 1990; 249: 655-659.
15. Wu J, Matthaei H, Maitra A, et al,. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011; 3: 92ra66.
16. Furukawa T, Kuboki Y, Tanji E, et al,. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 2011; 1: 161.
17. Yamada M, Sekine S, Ogawa R, et al,. Frequent activating GNAS mutations in villous adenoma of the colorectum. J Pathol 2012; 228: 113-118.
18. Buffart TE, Carvalho B, Mons T, et al,. DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics 2007; 8: 345.
19. Tajima Y, Yamazaki K, Makino R, et al,. Gastric and intestinal phenotypic marker expression in early differentiated-type tumors of the stomach: clinicopathologic significance and genetic background. Clin Cancer Res 2006; 12: 6469-6479.
20. Maesawa C, Tamura G, Suzuki Y, et al,. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol 1995; 176: 249-258.
21. Sakurai S, Sano T, Maeshima A, et al,. Gastric adenoma-carcinoma sequence with special reference to p53 and Ki-ras gene alterations. Virchows Arch 1995; 427: 119-124.
22. Endoh Y, Sakata K, Tamura G, et al,. Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 2000; 191: 257-263.
23. Lee JH, Abraham SC, Kim HS, et al,. Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol 2002; 161: 611-618.
24. Tsuchiya C, Ohshima S, Takahama M,. Detection of c-Ki-ras oncogene mutation in gastric adenomas with formalin-fixed, paraffin-embedded biopsy materials. J Gastroenterol 1997; 32: 28-33.
25. Abraham SC, Park SJ, Lee JH, et al,. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. Mod Pathol 2003; 16: 786-795.
26. Kihana T, Tsuda H, Hirota T, et al,. Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation. Jpn J Cancer Res 1991; 82: 308-314.
27. Wagner PL, Chen YT, Yantiss RK,. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa. Am J Surg Pathol 2008; 32: 1388-1395.
28. Lee SH, Jeong EG, Soung YH, et al,. Absence of GNAS and EGFL6 mutations in common human cancers. Pathology 2008; 40: 95-97.
29. Chetty R, Serra S,. Intraductal tubular adenoma (pyloric gland-type) of the pancreas: a reappraisal and possible relationship with gastric-type intraductal papillary mucinous neoplasm. Histopathology 2009; 55: 270-276.
30. Ban S, Naitoh Y, Mino-Kenudson M, et al,. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between two major types. Am J Surg Pathol 2006; 30: 1561-1569.
31. Kato N, Akiyama S, Motoyama T. Pyloric gland-type tubular adenoma superimposed on intraductal papillary mucinous tumor of the pancreas. Pyloric gland adenoma of the pancreas. Virchows Arch 2002; 440: 205-208.
32. Shia J., Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn 2008; 10: 293-300.
33. Ohmura K, Tamura G, Endoh Y, et al,. Microsatellite alterations in differentiated-type adenocarcinomas and precancerous lesions of the stomach with special reference to cellular phenotype. Hum Pathol 2000; 31: 1031-1035.
34. Yamazaki K, Tajima Y, Makino R, et al,. Tumor differentiation phenotype in gastric differentiated-type tumors and its relation to tumor invasion and genetic alterations. World J Gastroenterol 2006; 12: 3803-3809.
35. Fang DC, Wang RQ, Yang SM, et al,. Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability. World J Gastroenterol 2003; 9: 655-659.
36. Seo HM, Chang YS, Joo SH, et al,. Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype. J Surg Oncol 2009; 99: 143-147.
37. Leite M, Corso G, Sousa S, et al,. MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer 2011; 128: 1606-1613.